Dec 2024: The Year in Patent Reform
I-MAK’s Quest To Trim The Biopharmaceutical Patent Thicket

The Next Pandemic with Priti Krishtel and Tahir Amin
Big Pharma fights patent disclosure demand from investors

Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
Patent reform and lower drug prices should be bipartisan priorities

How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
How AbbVie denied Americans access to fair competition for Humira

Life-Changing Drug Costs Over $3,000 in US, $0 to $225 in Europe

Report pulls no punches in critique of drug patent abuse